Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Appl Toxicol ; 35(9): 1040-8, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25611945

ABSTRACT

Although several previous studies have demonstrated the presence of equine estrogens in the aquatic environment, limited data are currently available on the endocrine-disrupting potentials in fish and the risks they pose to aquatic organisms. To investigate the interactions of major equine estrogens equilin (Eq) and equilenin (Eqn), as well as their metabolites 17α-dihydroequilin, 17ß-dihydroequilin, 17α-dihydroequilenin and 17ß-dihydroequilenin, with the estrogen receptor α (ERα) of medaka (Oryzias latipes), a three-dimensional model of the ligand-binding domain (LBD) of ERα was built in silico, and docking simulations were performed. The docking simulation analysis indicated that the interaction of 17ß-dihydroequilenin with the ERα LBD is the most potent, followed by those of 17α-dihydroequilin and 17ß-dihydroequilin, whereas those of Eq and Eqn were least potent. We further analyzed gene expression profiles in the livers of male medaka exposed to Eq and Eqn. A DNA microarray representing 6000 genes revealed that 24-h exposure to Eq and Eqn (100 ng/L) upregulated the expression of 6 and 34 genes in the livers of males, respectively. Genes upregulated by Eq included the estrogenic biomarker genes vitellogenins and choriogenins, suggesting the estrogenic potential of Eq. In contrast, Eqn exposure upregulated several cancer-related genes, such as mediator complex subunit 16 and RAS oncogene family members, suggesting a carcinogenic potential for Eqn. These results suggest that equine estrogens may have not only endocrine-disrupting potentials via the ERα signaling pathway but also carcinogenic potency in male medaka.


Subject(s)
Endocrine Disruptors/toxicity , Equilenin/toxicity , Equilin/toxicity , Liver/drug effects , Oryzias/metabolism , Water Pollutants, Chemical/toxicity , Animals , Endocrine Disruptors/metabolism , Equilenin/metabolism , Equilin/metabolism , Estrogen Receptor alpha/metabolism , Estrogen Receptor beta/metabolism , Ligands , Liver/metabolism , Male , Molecular Docking Simulation , Oligonucleotide Array Sequence Analysis , Protein Binding , Transcriptome/drug effects , Water Pollutants, Chemical/metabolism
2.
Carcinogenesis ; 24(5): 911-7, 2003 May.
Article in English | MEDLINE | ID: mdl-12771036

ABSTRACT

Increased incidence of breast, ovarian and endometrial cancers are observed in women receiving estrogen replacement therapy (ERT). Equilin and equilenin are the major components of the widely prescribed drug used for ERT. These equine estrogens are metabolized primarily to 4-hydroxyequilin (4-OHEQ) and 4-hydroxyequilenin, respectively, which are autoxidized to react with DNA, resulting in the various DNA damages. To explore the mutagenic potential of equine estrogen metabolites, a double-stranded pMY189 shuttle vector carrying a bacteria suppressor tRNA gene, supF, was exposed to 4-OHEQ and transfected into human fibroblast. Plasmids containing mutations in the supF gene were detected with indicator bacteria and mutated colonies obtained were analyzed by automatic DNA sequencing. The proportion of plasmids with the mutated supF gene was increased dose-dependently. The majority of the 4-OHEQ-induced mutations were base substitutions (78%); another 22% were deletions and insertions. Among the base substitutions, 56% were single base substitutions and 19% were multiple base substitutions. The majority (86%) of the 4-OHEQ-induced single base substitutions occurred at the C:G site. C:G --> G:C and C:G --> A:T mutations were detected preferentially with lesser numbers of C:G --> T:A transitions. Sixty-two percent of base substitutions were observed particularly at C:G pairs in (5')-TC/AG-(5') sequences. Using (32)P-post-labeling/gel electrophoresis analysis, 4-OHEN-dC was a major adduct, followed by lesser amounts of 4-OHEN-dA adduct. Mutations observed at C:G pairs may result from 4-OHEN-dC adduct. These results indicated that 4-OHEQ is mutagenic, generating mutations primarily at C:G pairs in (5')-TC/AG-(5') sequences.


Subject(s)
DNA Adducts/genetics , Equilin/analogs & derivatives , Equilin/toxicity , Estradiol Congeners/toxicity , Genetic Vectors , Mutation/genetics , Plasmids/genetics , RNA, Transfer/genetics , Base Sequence , DNA Replication , Escherichia coli , Fibroblasts/drug effects , Fibroblasts/metabolism , Genes, Suppressor , Humans , Molecular Sequence Data , Molecular Structure , Mutagenicity Tests , RNA, Transfer/metabolism , Suppression, Genetic , Transfection
3.
Drug Chem Toxicol ; 25(1): 75-82, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11850971

ABSTRACT

Recently, we investigated the inhibitory effects of 17 beta-estradiol and diethylstilbestrol on microtubule assembly, cytotoxicity, and aneuploidy in V79 cells. The present study analyzes the effects of equilin and equilenin (amongst the natural estrogens originally isolated from the urine of pregnant horses) and their related compounds, on the relative plating efficiency of Chinese hamster V79 cells. The results showed that a hydroxyl group on 17-C and a methoxyl group on 3-C of the estrogen skeleton were important for cytotoxicity. Of the various compounds analyzed, 2-methoxyestradiol had the strongest cytotoxicity, suggesting also the importance of a methoxyl group on 2-C.


Subject(s)
Equilenin/toxicity , Equilin/toxicity , Estradiol/analogs & derivatives , Estradiol/toxicity , 2-Methoxyestradiol , Animals , Cell Division/drug effects , Cell Line , Cricetinae , Dose-Response Relationship, Drug , Equilenin/chemistry , Equilin/chemistry , Estradiol/chemistry , Estrone/toxicity , Structure-Activity Relationship , Toxicity Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...